Our Chairman and CEO, Don Segal, PhD. has a long and distinguished career in the biopharmaceutical and biotechnology industries, which spans over 40 years. Dr. Segal founded Helix Biopharma Corp. where he was instrumental in inventing the lung cancer candidate drug L-DOS47, currently in clinical trials. Dr. Segal was introduced to Cold-Q a few years ago, and after doing his due diligence he believed in the product’s potential for cold and flu relief. Given Dr. Segal’s background in cancer therapeutics, he saw another opportunity and that was to help the most vulnerable, those with a compromised immune system. And with that in mind, he personally invested in the product to help brand, and gain awareness of the product.